Upstream Bio

Upstream Bio(UPB)

WALTHAM, MA
Biotechnology

Focus: Therapies for allergic, inflammatory conditions

Upstream Bio is a life sciences company focused on Therapies for allergic, inflammatory conditions.

OncologyImmunology
Funding Stage
PUBLIC
Employees
51-200
Open Jobs
0

Pipeline & Clinical Trials

UPB-101
Asthma
Phase 1
Clinical Trials (1)
NCT05448651Safety and Biologic Impact (Pharmacodynamics) of Repeated Injections and Increasing Amounts of UPB-101 in Asthmatics
Phase 1
UPB-101
Healthy
Phase 1
Clinical Trials (1)
NCT05653479Safety and Blood Levels After a Single Injection of UPB-101 in Healthy Japanese and Non-Japanese Non-East Asian Adults
Phase 1
Clinical Trials (1)
NCT06981078A Study to Assess the Efficacy and Safety of Verekitug in Participants With COPD
Phase 2
Clinical Trials (1)
NCT06164704A Study to Investigate the Efficacy and Safety of Verekitug (UPB-101) in Participants With Chronic Rhinosinusitis With Nasal Polyps
Phase 2
Verekitug
Severe Asthma
Phase 2
Clinical Trials (1)
NCT06966479A Long-Term Safety and Efficacy Study of Verekitug (UPB-101) in Adult Participants With Severe Asthma (VALOUR)
Phase 2
Verekitug
Severe Asthma
Phase 2
Clinical Trials (1)
NCT06196879A Study to Investigate the Efficacy and Safety of Verekitug (UPB-101) in Adult Participants With Severe Asthma (VALIANT)
Phase 2

Open Jobs (0)

No open positions listed yet. Check their careers page directly.

Interview Prep Quick Facts
Founded: 2022
Portfolio: 6 clinical trials
SEC Filings: 1 available

Financials (FY2024)

Revenue
$2M
R&D Spend
$32M(1336%)
Net Income
-$21M
Cash
$26M